首页> 外文期刊>Journal of Neurology, Neurosurgery and Psychiatry >Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations
【24h】

Changing antiepilepsy drug-prescribing trends in women with epilepsy in the UK and Ireland and the impact on major congenital malformations

机译:在英国和爱尔兰癫痫患有癫痫患者的抗癫痫药物规定趋势以及对重大先天性畸形的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives After 20 years of data collection, pregnancy registers have informed prescribing practice. Various populations show trends for a reduction in valproate prescribing, which is associated with an increased risk of anatomical teratogenesis and neurodevelopmental effects in those exposed in utero. Our aim was to determine if any shifts in prescribing trends have occurred in the UK and Ireland Epilepsy and Pregnancy Register cohort and to assess if there had been any change in the overall major congenital malformation (MCM) rate over time. Methods The UK and Ireland Epilepsy and Pregnancy Register, a prospective, observational, registration and follow-up study established in 1996, was used to determine the changes in antiepileptic drugs (AEDs) utilised during pregnancy and the MCM rate between 1996 and 2016. Linear regression analysis was used to assess changes in AED utilisation, and Poisson regression was used for the analysis of trends in the MCM rates. Results Outcome data for 9247 pregnancies showed a stable percentage of monotherapy to polytherapy prescribing habits over time. After Bonferroni correction, statistically significant (p<0.003) changes were found in monotherapy prescribing with increases in lamotrigine and levetiracetam and decreases in valproate and carbamazepine use. Between 1996 and 2016, the total MCM rate showed a 2.1% reduction per year (incidence risk ratio 0.979 (95% CIs 0.956 to 1.002) but Poisson regression analysis showed that this was not statistically significant p=0.08). Conclusion Significant changes are seen in the prescribing habits in this cohort over 20 years, but a statistically significant change in the MCM rate was not detected. This work should be replicated on a larger scale to determine if significant changes are occurring in the MCM rate, which would allow a robust economic estimate of the benefits of improvements in prescribing practice and the personal effect of such changes.
机译:目标经过20年的数据收集后,怀孕寄存器已经了解了规定的实践。各种群体表明丙戊糖规定的减少的趋势,这与在子宫内暴露的人中的解剖学致畸作用和神经发育效果的风险增加有关。我们的目标是确定在英国和爱尔兰癫痫和怀孕登记队中是否发生了处方趋势的任何班次,并评估了总体主要先天性畸形(MCM)率随着时间的推移。方法采用1996年建立的英国和爱尔兰癫痫和怀孕寄存器,预期,观察,登记和后续研究,用于确定在怀孕期间使用的抗癫痫药物(AEDs)的变化以及1996年至2016年间的MCM率。线性回归分析用于评估AED利用的变化,泊松回归用于分析MCM率的趋势。结果9247次妊娠的结果数据表明,随着时间的推移,单药治疗的稳定百分比对多疗法的植物。在Bonferroni校正之后,在单疗法中发现统计学意义(P <0.003)变化,随着苜蓿和Levetiracetam的增加,并降低了丙丙酮和卡巴西肽使用。在1996年至2016年期间,MCM总数每年减少2.1%(发病风险比率0.979(95%CIS 0.956至1.002),但泊松回归分析表明,这在统计学上没有明显的p = 0.08)。结论20年多的处方习惯中的规定习惯看到了显着变化,但未检测到MCM速率的统计学显着变化。应该在更大的比例上复制这项工作,以确定是否在MCM速率下发生了重大变化,这将允许强大的经济估计在规定实践方面的改善益处和这种变化的个人效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号